Dipyridamole combined with immunoglobulin and aspirin in the treatment of Kawasaki disease in children: a meta-analysis - Top-Institutions - MDSpire

Dipyridamole combined with immunoglobulin and aspirin in the treatment of Kawasaki disease in children: a meta-analysis

By
Yanshuo Shi
Xin Xu
Yuanyuan Yue
Jianqun Zhao
Kaiqing Yao
Huizhen Wu
June 29, 2026
0 min

Frontiers In Medicine

Share

Top Institutions in Pediatrics

Brief introduction explaining scope and methodology.

#1

University of California San Diego (UC San Diego) School of Medicine and Rady Children’s Hospital–San Diego

La Jolla, California
Key Differentiators
- Kawasaki Disease
- Pediatrics
#2

Boston Children’s Hospital

Boston, Massachusetts
Key Differentiators
- Kawasaki Disease
- Pediatrics
#3

Children’s Hospital of Chongqing Medical University

Chongqing, China
Key Differentiators
- Pediatrics
#4

University Hospital “Marqués de Valdecilla”

Santander, Spain
Key Differentiators
- Pediatrics
#5

Pediatric Heart Network

North America, USA
Key Differentiators
- Pediatrics

Original Source(s)

Frontiers In Medicine

Dipyridamole combined with immunoglobulin and aspirin in the treatment of Kawasaki disease in children: a meta-analysis

by Yanshuo Shi, Xin Xu, Yuanyuan Yue, Jianqun Zhao, Kaiqing Yao, Huizhen Wu
June 29, 2026

Related Content

Jama Network Open

Needs and Perspectives on Upper Limb Prostheses Among Children and Adolescents With Upper Limb Differences

Frontiers In Pediatrics

Research progress on testicular torsion secondary to inguinal cryptorchidism

by Qingyu Xu, Lin Zhang, Nan Cong, Yi Song, Qi Shi
June 25, 2026

Frontiers In Pediatrics

An exploratory pre–post study of an intensive somatosensory activity-based intervention on participation-related goals, motor performance and somatosensory function in children with unilateral cerebral palsy